Table 4.
Linear regression analysis comparing patient cohorts with Valcyte treatment versus placebo
CD 3 cells | Regression coefficient | p value |
---|---|---|
0 weeks | −0.1510336 | 0.2173 |
3 weeks | 0.139136 | 0.4 |
12 weeks | −0.1315498 | 0.3092 |
24 weeks | −0.0630347 | 0.8129 |
CD 4+ cells | ||
0 weeks | −0.0385455 | 0.6983 |
3 weeks | −0.0523832 | 0.5933 |
12 weeks | 0.0612635 | 0.5189 |
24 weeks | −0.0246153 | 0.7993 |
CD 8+ cells | ||
0 weeks | 0.1092555 | 0.4089 |
3 weeks | 0.3792077 | 0.0462 |
12 weeks | 0.00146 | 0.9925 |
24 weeks | 0.205801 | 0.2462 |
GD T cells | ||
0 weeks | −0.4969697 | 0.0891 |
3 weeks | −0.3266768 | 0.3045 |
12 weeks | 0.0294959 | 0.9175 |
24 weeks | −0.0437197 | 0.8812 |
CD 4/CD 57 cells | ||
0 weeks | −0.2710945 | 0.3597 |
3 weeks | −0.1967002 | 0.5725 |
12 weeks | 0.2718693 | 0.3706 |
24 weeks | −0.4021137 | 0.1652 |
CD 8/CD 57 cells | ||
0 weeks | 0.1518069 | 0.6128 |
3 weeks | −0.1124162 | 0.6826 |
12 weeks | −0.0695953 | 0.8608 |
24 weeks | −0.2129092 | 0.4692 |
CD 4/CD 28null cells | ||
0 weeks | 0.312091 | 0.3743 |
3 weeks | −0.5047389 | 0.1493 |
12 weeks | −0.0089941 | 0.9803 |
24 weeks | −0.4274857 | 0.1648 |
CD 8/CD 28null cells | ||
0 weeks | 0.1306234 | 0.6972 |
3 weeks | 0.0858196 | 0.8044 |
12 weeks | −0.0895841 | 0.6666 |
24 weeks | −0.4305437 | 0.1522 |
CD 4/ CD57/CD 28null cells | ||
0 weeks | 1.110387 | 0.0673 |
3 weeks | 1.203756 | 0.058 |
12 weeks | 0.1420544 | 0.7847 |
24 weeks | 0.5643537 | 0.3595 |
CD 8/ CD57/CD 28null cells | ||
0 weeks | −0.0155809 | 0.9756 |
3 weeks | −0.6119404 | 0.137 |
12 weeks | 0.3224287 | 0.3278 |
24 weeks | −0.6235189 | 0.1541 |
CD 4/CD 25 cells | ||
0 weeks | −0.21233 | 0.6179 |
3 weeks | 0.7711318 | 0.0947 |
12 weeks | 0.4433576 | 0.1565 |
24 weeks | 0.1041078 | 0.7244 |
CD 8/CD 25 cells | ||
0 weeks | 0.1311385 | 0.7944 |
3 weeks | 0.2672356 | 0.5469 |
12 weeks | 0.6383185 | 0.2732 |
24 weeks | 0.0276734 | 0.9453 |